Podcasts about Cancer prevention

EPISODE DESCRIPTIONRebecca V. Nellis never meant to run a nonprofit. She just never left. Twenty years later, she's still helming Cancer and Careers after a Craigslist maternity-leave temp job turned into a lifelong mission.In this 60-minute doubleheader, we cover everything from theater nerdom and improv rules for surviving bureaucracy, to hanging up on Jon Bon Jovi, to navigating cancer while working—or working while surviving cancer. Same thing.Rebecca's path is part Second City, part Prague hostel, part Upper East Side grant writer, and somehow all of that makes perfect sense. She breaks down how theater kids become nonprofit lifers, how “sample sale feminism” helped shape a cancer rights org, and how you know when the work is finally worth staying for.Also: Cleavon Little. Tap Dance Kid. 42 countries. And one extremely awkward moment involving a room full of women's handbags and one very confused Matthew.If you've ever had to hide your diagnosis to keep a job—or wanted to burn the whole HR system down—this one's for you.RELATED LINKSCancer and CareersRebecca Nellis on LinkedIn2024 Cancer and Careers Research ReportWorking with Cancer Pledge (Publicis)CEW FoundationI'm Not Rappaport – Broadway InfoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship opportunities, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Hoffman continues his conversation with Dr. Alexandra Shustina, NYC's and Miami's premier Integrative board-certified Gastroenterologist and gut health specialist, an expert in the gut microbiome and its role in health and wellness.

In this episode of the Intelligent Medicine podcast, Dr. Ronald Hoffman is joined by Dr. Alexandra Shustina, a distinguished integrative gastroenterologist based in New York City and Miami. They delve into Dr. Shustina's journey from conventional to integrative medicine, the importance of addressing the microbiome, and holistic approaches to treating gastrointestinal ailments like IBS, Crohn's disease, and ulcerative colitis. Dr. Shustina shares her insights on diet, the impact of stress, and the role of supplements and herbal remedies. She discusses the significance of personalized care, visceral manipulation, and mind-body techniques in promoting gut health. The episode also touches on the rising incidence of gastrointestinal cancers in young people and the potential benefits of proactive, integrative healthcare approaches.

This life-saving conversation is for anyone who has—or loves someone who has—breasts. It's what to look for, what to ask, what screenings you *actually need* (not just what is offered), and every decision point you have (even if it's not offered to you) if you are facing surgery.   This Breast Cancer Awareness Month, Glennon, Abby, and Amanda empower us with the most vital tool we have: information. Amanda reflects on how self-advocacy led her to her own breast cancer diagnosis—and we hear from the pod squad about how Amanda's transparency helped save their lives. Then, we're joined by Amanda's renowned doctor, Dr. Lucy M. De La Cruz, who reminds us that every patient has agency—and shares how to choose the treatment path that's right for you. And special shout out and thanks to Pod Squader Lori Mihalich-Levin (@mindfulreturn) for being such a special part of this story! If you or someone you love has been diagnosed with breast cancer, please save this episode or send it to the people you love. We love you.  For more on Amanda's Breast Cancer journey:  - Amanda's Diagnosis and What's Next (Part 1) - Amanda's Diagnosis and What's Next (Part 2) - Amanda Returns Post Surgery: Here's What She Wants You to Know  - What Amanda's Learned About Life, Love & Community (Post Surgery Pt 2)  - Early Detection, Mammograms & Breast Cancer Care with Dr. Rachel Brem  - Expert Advice on Genetic Testing, Cancer Prevention & Care Disparities with Dr. Rachel Brem  About Dr. De La Cruz:  Dr. Lucy M. De La Cruz is an internationally recognized breast surgical oncologist and the youngest Latina Chief of Breast Surgery in an academic institution in the United States. She serves as Chief of Breast Surgery and Director of the Betty Lou Ourisman Breast Health Center at MedStar Georgetown University Hospital, a nationally ranked center of excellence in breast cancer care. Dr. De La Cruz specializes in nipple-sparing mastectomies with structural preservation and resensation, with a focus on highly specialized single-stage implant reconstruction. Patients describe her not only as a world-class surgeon, but as a fierce advocate and mentor—especially for women navigating the complexities of diagnosis, treatment, and survivorship. 

Sally Wolf is back in the studio and this time we left cancer at the door. She turned 50, brought a 1993 Newsday valedictorian article as a prop, and sat down with me for a half hour of pure Gen X therapy. We dug into VHS tracking, Red Dawn paranoia, Michael J. Fox, Bette Midler, and how growing up with no helmets and playgrounds built over concrete somehow didn't kill us.We laughed about being Jewish kids in the suburbs, the crushes we had on thirty-year-olds playing teenagers, and what it means to hit 50 with your humor intact. This episode is part nostalgia trip, part roast of our own generation, and part meditation on the privilege of being alive long enough to look back at it all. If you ever watched Different Strokes “very special episodes” or had a Family Ties lunchbox, this one's for you.RELATED LINKSSally Wolf Official WebsiteSally Wolf on LinkedInSally Wolf on InstagramCosmopolitan Essay: “What It's Like to Have the ‘Good' Cancer”Oprah Daily: “Five Things I Wish Everyone Understood About My Metastatic Breast Cancer Diagnosis”Allure Breast Cancer Photo ShootTom Wilson's “Stop Asking Me the Question” SongFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Show notes and links: https://www.chrisbeatcancer.com/dr-gerry-curatola-on-oral-health-fluoride-and-cancer-prevention

Science now links alcohol to seven types of cancer, brain shrinkage, hormonal chaos, and accelerated aging. Even one drink per night can destroy gray and white matter, sabotage detoxification, and cost high achievers hundreds of thousands in lost productivity. In this episode, I speak with James Swanwick, founder of Alcohol Free Lifestyle, about how alcohol disrupts everything from liver function to sleep quality. He also shares real stories of clients who reversed health complications, saved marriages, and dramatically increased their income after going alcohol-free. We explore how alcohol affects entrepreneurs and executives, why it blocks fat metabolism and hormone regulation, and practical strategies to quit without willpower, AA, or feeling deprived.   "Each drink that you choose to drink is costing you $684.93. That's a pretty damn expensive cocktail." ~ James Swanwick   In This Episode: - James's background and journey to alcohol-free living - Health risks of alcohol - Debunking the "one glass of wine is healthy" myth - What alcohol does to your liver, hormone function, and sleep quality - How alcohol increases appetite, and blocks fat burning - The financial cost of drinking for high performers - Alcohol's effect on brain volume and cognitive function - Real client stories of health, clarity, and redemption - Strategies to stop drinking without feeling deprived - Spiritual clarity, intuition, and a deeper connection to self - Transition tactics and avoiding willpower traps   Products & Resources Mentioned: Bon Charge Red Light Face Mask: Get 15% off at https://boncharge.com with code WENDY, plus free shipping and a 12-month warranty. Tru Energy Lip Peptide Treatment: Visit https://trytruenergy.com/wendy3 to claim your Buy One, Get One Free offer for a limited time. Qualia Senolytic: Get 15% off with code WENDY at https://qualialife.com/wendy  Heavy Metals Quiz: Find out if heavy metals are impacting your energy, mood, and overall health at https://heavymetalsquiz.com    About James Swanwick: James Swanwick is an Australian-American entrepreneur, author, and former ESPN SportsCenter anchor, best known for helping high achievers overcome alcohol addiction. He founded Alcohol Free Lifestyle, a program designed to help business owners and executives quit drinking without relying on AA, rehab, or willpower. Through programs like the 30 Day No Alcohol Challenge and Project 90, Swanwick has empowered thousands of individuals to make lasting transformations. He is also the CEO of Swanwick Sleep, a company specializing in blue light blocking glasses, and author of the book Clear: The Only Neuroscience-Based Method for High Achievers to Finally Break Free from Alcohol. After quitting drinking 15 years ago, James lost 13 pounds in 30 days, landed his ESPN job, and discovered a completely transformed approach to health, relationships, and business success. Learn more at: https://alcoholfreelifestyle.com    Disclaimer The Myers Detox Podcast was created and hosted by Dr. Wendy Myers. This podcast is for information purposes only. Statements and views expressed on this podcast are not medical advice. This podcast, including Wendy Myers and the producers, disclaims responsibility for any possible adverse effects from using the information contained herein. The opinions of guests are their own, and this podcast does not endorse or accept responsibility for statements made by guests. This podcast does not make any representations or warranties about guests' qualifications or credibility. Individuals on this podcast may have a direct or indirect financial interest in products or services referred to herein. If you think you have a medical problem, consult a licensed physician.

Dr. Nikki Maphis didn't just lose a grant. She lost a lifeline. An early-career Alzheimer's researcher driven by her grandmother's diagnosis, Nikki poured years into her work—only to watch it vanish when the NIH's MOSAIC program got axed overnight. Her application wasn't rejected. It was deleted. No feedback. No score. Just gone.In this episode, Oliver Bogler pulls back the curtain on what happens when politics and science collide and promising scientists get crushed in the crossfire. Nikki shares how she's fighting to stay in the field, teaching the next generation, and rewriting her grant for a world where even the word “diversity” can get you blacklisted. The conversation is raw, human, and maddening—a reminder that the real “war on science” doesn't happen in labs. It happens in inboxes.RELATED LINKS:• Dr. Nikki Maphis LinkedIn page• Dr. Nikki Maphis' page at the University of New Mexico• Vanguard News Group coverage• Nature article• PNAS: Contribution of NIH funding to new drug approvals 2010–2016FEEDBACK:Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, visit outofpatients.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Hoffman continues his conversation with Dr. Geo Espinosa, one of America's foremost integrative urologists.

Dr. Geo Espinosa, one of America's foremost integrative urologists, dishes on men's urinary problems, natural support for testosterone, and prostate cancer. Lifestyle factors—diet, exercise, sleep and stress reduction—play an important role in all phases of urological health. Dr. Geo explains how he interacts with conventional urologists on the faculty of NYU Langone Medical Center where he practices. Why are men's urinary problems not just a matter of prostate size? How can natural strategies alleviate urinary difficulties without the need for surgery or drugs? Besides saw palmetto, what nutraceuticals can benefit men with urinary problems? Are there really natural herbal alternatives to testosterone? For men with prostate cancer who are under active surveillance, is there anything more that can be done to minimize their chance of eventually needing surgery or radiation? What nutraceuticals, vitamins and minerals have anti-prostate cancer potential?

Welcome to the award-winning The Hill Country Podcast. The Texas Hill Country is one of the most beautiful places on earth. In this podcast, Hill Country resident Tom Fox visits with the people and organizations that make this the most unique area of Texas. This week, Tom welcomes Melissa Sanchez, the Senior Director of Public Policy at the Alzheimer's Association, to discuss her role and key initiatives, including Proposition 14. Melissa shares insights into her professional journey, emphasizing the importance of public policy in shaping lived experiences. The discussion delves into Proposition 14, a significant initiative aiming to transfer $3 billion over ten years to support the Dementia Prevention and Research Institute of Texas, mirroring the success of the Cancer Prevention and Research Institute of Texas. Melissa highlights the Alzheimer's Association's multifaceted approach, including care and support, research advancement, and advocacy, while addressing the broader economic and social impacts of dementia. The episode concludes with a call to action for listeners to support Proposition 14 and get involved with the Alzheimer's Association. Key highlights: Melissa Sanchez's Professional Journey Current Role and Proposition 14 Overview Alzheimer's Association Mission and Impact Challenges in Alzheimer's Advocacy Public Health Importance of Dementia How to Support Proposition 14 Resources: Alzheimer's Association website “Vote YES on Proposition 14” campaign Instagram: @alztex X (formerly Twitter): @alztex Facebook: Alzheimer's Association Texas Chapter Other Hill Country Focused Podcasts Hill Country Authors Podcast Hill Country Artists Podcast Texas Hill Country Podcast Network Cover Art Nancy Huffman

Carla Tardiff has spent 17 years as the CEO of Family Reach, a nonprofit that shouldn't have to exist but absolutely does—because in America, cancer comes with a price tag your insurance doesn't cover.We talk about shame, fear, burnout, Wegmans, Syracuse, celebrity telethons, and the godforsaken reality of choosing between food and treatment. Carla's a lifer in this fight, holding the line between humanity and bureaucracy, between data and decency. She's also sharp as hell, deeply funny, and more purpose-driven than half of Congress on a good day.This episode is about the work no one wants to do, the stuff no one wants to say, and why staying angry might be the only way to stay sane.Come for the laughs. Stay for the rage. And find out why Family Reach is the only adult in the room.RELATED LINKSFamily ReachFinancial Resource CenterCarla on LinkedInMorgridge Foundation ProfileAuthority Magazine InterviewSyracuse University FeatureFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Die Themen in den Wissensnachrichten: +++ Europäer trinken im weltweiten Vergleich am meisten Alkohol - mit Folgen +++ Elektroschrott: Milliardenschwere Ressource +++ Sport trainiert auch unsere Immunabwehr +++**********Weiterführende Quellen zu dieser Folge:Alcohol Policies Volume 20B, IARC Handbooks of Cancer Prevention, WHO, 20252050 Critical Raw Materials Outlook for Waste Electrical and Electronic in the European Union plus Iceland, Norway, Switzerland and United Kingdom, United Nations Institute for Training and Research, Technische Universität Berlin, WEEE Forum, ecosystem, 14.10.2025Natural killer cells from endurance-trained older adults show improved functional and metabolic responses to adrenergic blockade and mTOR inhibition, Scientific Reports, 14.07.2025Antarctic seep emergence and discovery in the shallow coastal environment, Nature Communications, 01.10.2025Cognitive decline before and after mid-to-late-life smoking cessation: a longitudinal analysis of prospective cohort studies from 12 countries, The Lancet Healthy Longevity, 13.10.2025Alle Quellen findet ihr hier.**********Ihr könnt uns auch auf diesen Kanälen folgen: TikTok und Instagram .

This one's personal. In this episode, I welcome Wes Fossile to share his powerful story—what began as dizziness and anxiety ended with the diagnosis of a brain tumor. Wes walks us through the fear, the MRI machines, the slow recovery, and ultimately, the birth of a mission: to make cancer risk quantifiable, preventable, and accessible to everyone.We unpack CatchBio, a revolutionary new AI-driven platform that calculates your personal cancer risk score and gives you a science-backed roadmap to lower it. Whether you're health-curious or deep into your own wellness journey, this conversation is a deep dive into how knowledge, awareness, and micro-adjustments can change everything. Cancer prevention doesn't have to be scary—it can be smart, empowering, and even simple. Episode Highlights [00:00] – The power of prevention: introducing CatchBio and personal cancer risk scores[02:19] – Movement and mindset: how Wes and I start our mornings with intention[05:32] – Wes's brain tumor diagnosis: from symptoms to surgery to recovery[11:15] – Mental health matters: panic attacks, therapy, and reclaiming peace post-surgery[16:41] – What CatchBio does—and how it makes cancer prevention measurable[20:51] – Simple changes, big impact: risk factors like hot drinks, mouthwash, and fruit intake[24:59] – The science behind the platform: how CatchBio builds its evolving model[33:17] – Avoiding fear-based health: why data is more powerful than doomscrolling[40:59] – What's coming next: wearables, chronic disease tracking, and behavior change integration[45:13] – Prevention is power: how $10/month might be the best investment in your health ​​Links & Resources Try CatchBio - https://www.catchbio.com/beautifullybroken— Use code BEAUTIFULLYBROKEN for a listener discountJoin the Biological Blueprint Program - https://www.beautifullybroken.world/BEAM Minerals: beamminerals.com/beautifullybrokenCode: BEAUTIFULLYBROKENLightPathLED: lightpathled.pxf.io/c/3438432/2059835/25794Code: beautifullybrokenSilver Biotics Wound Healing Gel: bit.ly/3JnxyDD30% off with Code: BEAUTIFULLYBROKENStemRegen: stemregen.co/products/stemregen?_ef_transaction_id=&oid=1&affid=52 CONNECT WITH FREDDIEWork with Me: https://www.beautifullybroken.world/biological-blueprintWebsite and Store: (http://www.beautifullybroken.world) Instagram: (https://www.instagram.com/beautifullybroken.world/) YouTube: (https://www.youtube.com/@freddiekimmel Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Examining the claim that cabbage family vegetables are bad for the thyroid; Walmart announces sweeping move to reformulate its products without synthetic dyes, sketchy additives; Under Congressional questioning, Google admits to censoring contrary narratives on YouTube during Covid; Children garner psychological benefits from grandparent time; J&J fined nearly $1 billion in landmark talc baby powder lawsuit; Humans are among the few animals who can't make their own vitamin C—why that may be a good thing.

The advent of artificial light is obliterating women's moon-driven menstrual cycle rhythms; When the triple whammy of cataracts, glaucoma, and macular degeneration strikes; Why can systolic blood pressure spike erratically? Are wrist and finger wearables for blood pressure ready for prime time? Nearly half of drivers killed in crashes have THC in their blood; Drinking bottled water causes surge in plastic micro-particle intake; The common supplement that can supercharge cancer immunotherapy.

Josh Monday Christian and Conspiracy Podcast Ep. 307How to Support the ministry: $5.99 a monthpatreon.com/JoshMondayChristianandConspiracyPodcastJoin the Patreon here: Linktree: https://linktr.ee/Joshmonday_podcastIf you want to donate to the Ministry CashAPP:https://cash.app/$JoshmondaymusicNew affiliate: https://wsteif.com/ Paul and Crystals links: https://thetinfoilhatfactory.com/Flat Earth Books by Sakal Publishing Affiliate Link: https://booksonline.club/booksonlinecYoutube: ⁠@joshmondaymusicandpodcast ⁠ Tips for the show to Support our Ministry: https://www.buymeacoffee.com/joshmondayCoffee Mug Is Available email me your mailing address Joshmonday⁠@rocketmail.com ⁠ Please subscribe to our Spotify and You Tube Channel Joshmondaymusic and Podcast and help us grow so we can keep on spreading the good news.To all of our current and future subscribers thank you for your time, we appreciate you. Please do us a favor subscribe to our You Tube Channel, hit that bell, share, like and comment below on our You tube. Please leave us a 5-Star review on Apple and Spotify.Check out my new show Sunday Service and Wednesday Brought to you by Cult of Conspiracy Podcast. On Cult of Conspiracy Spotify, Patreon and Apple Podcast Channel.Join the study as I go deep into the Bible. Faith cometh by hearing and hearing by the Word of God. Romans 10:17.Become a supporter of this podcast: https://www.spreaker.com/podcast/josh-monday-christian-and-conspiracy-podcast--6611118/support.

People under 50 are experiencing higher risk of some cancers. While overall cancer rates are declining, the incidence of 14 cancer types have increased in younger people. Why? It could be related to lifestyle choices, environmental factors, or an individual's genetics. In this episode, host Samantha Laine Perfas speaks with global cancer trend expert Tim Rebbeck, oncologist Kimmie Ng, and epidemiologist Tomotaka Ugai about how people under 50 can best mitigate their cancer risk.

Download the ⁠⁠Health Reboot Blueprint PDF: Five Red Flags Your Body is Crying Out for Help & How to Fix ThemIf you've been experiencing persistent low energy, weight fluctuations, sleep issues, a non-existent sex drive, or chronic inflammation, this episode is for you. Learn about the five commonly overlooked signs that your body needs help, understand what they mean, and discover practical resets to improve your health. Additionally, get informed on cancer prevention strategies, detailed Q&A on cancer treatments, and the importance of balancing your circadian rhythms, insulin levels, and reducing inflammation. Tune in for actionable steps to start enhancing your overall well-being today.00:00 Introduction: Signs Your Body Needs Help00:50 Q&A: Cancer Prevention and Treatment05:09 The Five Red Flags Your Body is Crying for Help05:52 Red Flag 1: Persistent Low Energy Levels12:23 Red Flag 2: Weight Fluctuations15:43 Red Flag 3: Sleep Issues17:27 Red Flag 4: Low or Non-Existent Sex Drive19:31 Red Flag 5: Chronic Inflammation23:04 Action Plan: Resetting Your Body29:05 Conclusion and Recap30:33 Disclaimer and Final Notes

Jennifer J. Brown is a scientist, a writer, and a mother who never got the luxury of separating those roles. Her memoir When the Baby Is Not OK: Hopes & Genes is a punch to the gut of polite society and a medical system that expects parents to smile through trauma. She wrote it because she had to. Because the people who gave her the diagnosis didn't give her the truth. Because a Harvard-educated geneticist with two daughters born with PKU still couldn't get a straight answer from the very system she trained in.We sat down in the studio to talk about the unbearable loneliness of rare disease parenting, the disconnect between medical knowledge and human connection, and what it means to weaponize science against silence. She talks about bias in the NICU, the failure of healthcare communication, and why “resilience” is a lazy word. Her daughters are grown now. One's a playwright. One's an artist. And Jennifer is still raising hell.This is a conversation about control, trauma, survival, and rewriting the script when the world hands you someone else's lines.Bring tissues. Then bring receipts.RELATED LINKS• When the Baby Is Not OK (Book)• Jennifer's Website• Jennifer on LinkedInFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, visit outofpatients.show.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On this month's episode of Cancer Registry World, we welcome our guest Alana Hudson, PhD, MPH, Assistant Professor in the Department of Cancer Prevention and Control at West Virginia University School of Medicine. Dr. Hudson shares her perspective as a cancer epidemiologist and highlights the essential role cancer registry data plays in advancing cancer prevention research. Join us for an insightful conversation that underscores the value of registries in improving population health.

This episode of Standard Deviation features Oliver Bogler in conversation with Dr Na Zhao, a cancer biologist caught in the crossfire of science, politics, and survival. Na's life reads like a brutal lab experiment in persistence.She grew up in China, lost her mother and aunt to breast cancer before she turned twelve, then came to the United States to chase science as both an immigrant and a survivor's daughter. She worked two decades to reach the brink of independence as a cancer researcher, only to watch offers and grants vanish in the political chaos of 2025.Oliver brings her story into sharp focus, tracing the impossible climb toward a tenure-track position and the human cost of a system that pulls the ladder up just as people like Na reach for it. This conversation pulls back the curtain on the NIH funding crisis, the toll on early-career scientists, and what happens when personal tragedy fuels professional ambition.Listeners will walk away with a raw sense of how fragile the future of cancer research really is, and why people like Na refuse to stop climbing.RELATED LINKSDr Zhao at Baylor College of MedicineDr Zhao on LinkedInDr Zhao's Science articleIndirect Costs explained by US CongressFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Monty Pal and Dr. Matteo Lambertini discuss a compelling global study on the clinical behavior of breast cancer in young BRCA1 and BRCA2 carriers, the association of pre-diagnostic awareness of BRCA status with prognosis, and the importance of identifying healthy people who are at risk of carrying the BRCA1/2 pathogenic variants. TRANSCRIPT Dr. Monty Pal: Well, hello everyone, and welcome to the ASCO Daily News Podcast. I'm your host, Dr. Monty Pal. I'm a medical oncologist, professor, and vice chair of medical oncology at the City of Hope Comprehensive Cancer Center in Los Angeles. Now, when we think about genetic testing, whether for patients diagnosed with breast cancer or for other family members of them, it seems to be widely underutilized. Today, we're going to be discussing a recently published study in the Journal of Clinical Oncology that reported on the clinical behavior of breast cancer and specifically young BRCA1 and BRCA2 carriers, and the association of pre-diagnostic awareness of BRCA status with prognosis. I thought this was just a fascinating piece, and I honestly couldn't wait to have this conversation. It's a really compelling paper that highlights the importance of identifying healthy people who are at risk of carrying the BRCA1/2 pathogenic variants, and really the need for genetic counseling and testing to inform people about early detection that could lead to a better prognosis. I'm really delighted to welcome the study's lead author, Dr. Matteo Lambertini. He really needs no introduction. He's very well known in the breast cancer world for his amazing contributions to fertility in the context of breast cancer, to pregnancy in the context of breast cancer, and genetic testing. He's an associate professor at the University of Genova, and a breast cancer medical oncologist at the San Martino Polyclinic Hospital in Genova, Italy.  Dr. Lambertini, thank you so much for joining us today. Dr. Matteo Lambertini: Thank you very much, Dr. Pal. It's a great pleasure. Dr. Monty Pal: Oh, thanks. And just FYI, if you're listening in and you want to hear our disclosures, they're all listed at the transcript of this podcast.  So, I poured through this paper [Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status] yesterday, Dr. Lambertini, and first of all, congratulations on this study. This was a huge international multicenter effort, 4,752 patients. How did you pool all these patients with young breast cancer? Dr. Matteo Lambertini: Thanks a lot for the question. Yes, this was an effort made by several centers all over the world. The main idea behind the creation of this network that we have named as BRCA BCY Collaboration, was to get as many data as possible in a sort of niche patient population in the breast cancer field, meaning women diagnosed with breast cancer at the age of 40 years or younger, and all of them being BRCA carriers. We know that around, in the Western world, around 5% of breast cancer cases are being diagnosed under the age of 40 years, and among them around 10-15% are BRCA carriers. So, I would say it's a relatively rare patient population where we did not have a lot of evidence to support our choices in terms of counseling on treatment, prevention, and oncofertility as well. That was the idea behind the creation of this network that includes many centers. Dr. Monty Pal: Yeah. You know, what's so interesting about this is that you sort of draw this line between patients who have BRCA testing at the time of diagnosis and then BRCA testing earlier in their course and then leading to a diagnosis perhaps. And I think that's where really sort of the dichotomy in outcome sits. Can you maybe elaborate on this and tell us about timing of genetic testing in this study and what that meant ultimately in terms of prognosis? Dr. Matteo Lambertini: In this specific analysis from this large network, including almost 5,000 women with breast cancer diagnosed at the age of 40 years or younger and being a BRCA carrier, we looked specifically into the timing of genetic testing because this is a retrospective study and the criteria for inclusion are those that I have just mentioned, so diagnosis at a young age plus carrying germline BRCA pathogenic or likely pathogenic variant. In this analysis, we have looked into the time the patient has got the genetic testing and particular we focused on two populations: those that were diagnosed, knowing already to be a BRCA carrier, and those that got tested after being diagnosed with breast cancer. And the main findings from this analysis have been that knowing to be a BRCA carrier was associated with a lower stage at the time of diagnosis, meaning more T1 tumors, so a tumor less than 2 cm, more node-negative disease, and this translated into less aggressive treatment, so less often axillary dissection, less often use of chemotherapy and anthracycline-based chemotherapy. And even more importantly, we have seen a better overall survival for those patients that were diagnosed already knowing to be BRCA carriers as compared to those tested after breast cancer diagnosis. These results after adjusting for all the confounding, stage, treatment and so on, there was not significant anymore, meaning that it's not the timing of test per se that is probably leading to a better survival, but it is the fact that knowing to be a BRCA carrier would likely translate into having access to all the preventive measures that we have in this setting and this will translate into an overall survival benefit, so in terms of saving more lives in young BRCA carriers. Dr. Monty Pal: I think it's such an important point, and it's one that I think might sound implicit, right, but it needs to be proven, I think, through a study like this. You know, the fact that finding this early, identifying the mutation, doing enhanced screening, and so forth, is really going to lead to superior clinical outcomes. One of the things that I think many people puzzle over, including myself, is what to do? I personally occasionally will see BRCA altered patients in the context of prostate cancer. But that's a very different population of individuals, right? Typically older men. In young females with BRCA mutation, I guess there's a specific set of considerations around reproductive health. You'd already highlighted preventive strategies, but what sorts of things should we be talking about in the clinics once a patient's diagnosed and once perhaps their breast cancer diagnosis is established? Dr. Matteo Lambertini: Yes, exactly. Knowing to be a BRCA carrier has a lot of implications from prevention to treatment to survivorship issues including reproductive counseling. And this is important not only for the patient that has been diagnosed with breast cancer but also for all the family members that will get tested and maybe identify with this sort of genetic alteration before diagnosis of cancer. Why this is important is because we have access to very effective preventive measures, a few examples: MRI screening, which starts at a very young age and normally young women don't have an effective screening strategy outside the BRCA field. Also, primary preventive measures, for example, risk-reducing surgery. These women are known to have a high risk of breast cancer and high risk of ovarian cancer. So the guidelines are suggesting to undergo risk-reducing salpingo-oophorectomy at a young age, so 35 to 40 years in BRCA1 carrier, 40 to 45 years in BRCA2 carrier. And also risk-reducing mastectomy should be discussed because it is a very effective way to prevent the occurrence of breast cancer. And in some situations, including the setting that we are talking about, so young women with breast cancer, BRCA carrier, also risk-reducing mastectomy has shown to improve overall survival.  On the other side, once diagnosed with breast cancer, nowadays knowing to be or not a BRCA carrier can make a difference in terms of treatment. We have PARP inhibitors in the early setting, in the adjuvant setting as well as in the metastatic setting. And in terms of survivorship implication, one of the critical aspects for young women is the oncofertility care which is even more complicated when we talk about BRCA carriers that are women candidates for gynecological surgery at a very young age. So this sort of counseling is even more complicated. Dr. Monty Pal: One of the other things, and this is subtle in your paper and I hope you don't mind me bringing it up, is the difference between BRCA1 and BRCA2. It really got me thinking about that because there are differences in phenotype and manifestation. Do you mind just expanding on that a little bit for the audience because I think that's a really important reminder that you brought up in the discussion? Dr. Matteo Lambertini: The difference between BRCA1 and BRCA2 carriers has been known that there are different phenotypes of breast cancer that are more often diagnosed in these two different populations. Normally BRCA1 carriers have a higher likelihood to develop a triple negative breast cancer as compared to BRCA2 carriers, more likely to develop a hormone receptor-positive HER2-negative disease. In this study, again, a specific population of young women with breast cancer, we have seen the same findings, mostly triple negative disease in BRCA1 carrier, mostly luminal-like disease in BRCA2 carrier. But what's novel or interesting from this study is to look also at the age at the time of diagnosis of this disease. And particularly in BRCA1 carriers, we should be sort of more careful about diagnosis of breast cancer and also other primary tumors including ovarian cancer because the risk of developing these malignancies is higher even at a younger age as compared to BRCA2 carriers. And this has implications also in the primary and secondary prevention that we were talking about earlier. Dr. Monty Pal: Oh, interesting. I guess the fundamental question then from your paper becomes, how do we get at the right patients for screening for BRCA1 and BRCA2? And I realize our audience here is largely oncologists who are going to be listening to this podcast, oncology providers, MDs, nurses, etc. But maybe speak for a moment to the general practitioner. Are there things that, for instance, a general practitioner should be looking for to say, “Wait a minute, this patient's high risk, we should consider BRCA1, BRCA2 testing or germline screening”? Dr. Matteo Lambertini: Yes, it's a very important question for the breast cancer community. After the updated ASCO guideline, the counseling is way easier because right now the age cutoff goes up to 65 years, meaning that all the patients diagnosed with breast cancer below the age of 65 years should be tested these days. And then above the age of 65, there are different criteria like triple-negative disease or family history. From a general practitioner standpoint, it's of course a bit more difficult, but knowing particularly the family history of the person that they have in front will be crucial to know if there are cases of breast cancer diagnosed at a young age, maybe triple-negative cases, knowing cases of ovarian cancer in first-degree relatives or pancreatic cancer in first-degree relatives, and of course cases of prostate cancer as well. So, I would say probably mostly the family side will be important from a general practitioner perspective.  From an oncology one, the other point that I think is important to stress also based on the data that we have shown in this publication is that having a case of breast cancer known to carry a BRCA pathogenic or likely pathogenic variant. It means that all the people around this case should get tested and if found to be BRCA carrier and healthy carrier, these people should also undergo the primary and secondary prevention strategies because this is very critical also to improve their outcomes and try to avoid the developing of breast or ovarian cancer, but also in the case of diagnosis of this disease, a diagnosis at an earlier stage, as we have seen in this paper. Dr. Monty Pal: Brilliant. I'm going to diverge from our list of questions here and close by asking a question that I have at the top of my mind. You're very young. I know our podcast listeners can't see you, but you're very, very young. Dr. Matteo Lambertini: Thank you. Thank you for that. Not so young but yeah. Dr. Monty Pal: You have nearly 300 papers. Your H-index is 67. You've already made these seminal contributions, as I outlined it from the outset, regarding fertility, regarding use of GnRH analogs, regarding pregnancy and breast cancer. What are you studying now? What are you really excited about right now that you're doing that you think might potentially be practice changing? Give us a little teaser. Dr. Matteo Lambertini: Yeah. Thanks a lot, Dr. Pal. Receiving this compliment from you is fantastic. So, thanks a lot for that. From my side, in terms of my research, I've been interested in the field of breast cancer in young women since the start of my training. I've had very good mentors from Italy, from Europe, from the U.S. I'm still interested in this field, so I think we still have a lot to learn to try to improve the care of young women with breast cancer. For example, the oncofertility care, which is something I worked a lot over the past years. Now with all the new treatment options, there's a sort of new chapter of oncofertility counseling. So, what's the impact of immunotherapy? What's the impact of the new targeted agents?  More on the genetic aspects, now we know that there's not only BRCA1 or BRCA2. There are a lot of other different genes that may increase the risk of breast cancer and other malignancies. And also for these genes, we really don't have a lot of evidence to counsel women on prognosis, treatment, prevention strategy. So we need to learn way more for this special patient population that are quite rare, and so we really need a multicenter academic effort to try to give some evidence in this field. Dr. Monty Pal: Yeah. It's tough because these are rare circumstances, but, you know, I think that you've done really well to sort of define some collective experiences that I think really define therapy. I mean, I just remember when I was in training 25 years ago, just reading through textbooks where all the experience around breast cancer and pregnancy was really just very sort of anecdotal almost, you know? And so it's great to see that the state of the science has moved forward.  Well, gosh, I really enjoyed our conversation today. I think your study really reminds us how powerful genetic information is in terms of improving outcomes. And, you know, hopefully this will lead some individuals to perhaps test more broadly in appropriate settings. So, thank you so much, Matteo, for joining us today with your fantastic insights on the ASCO Daily News Podcast. Dr. Matteo Lambertini: Thank you very much, Dr. Pal. It's a real pleasure. Dr. Monty Pal: And thanks to our listeners too. You'll find a link to Dr. Lambertini's study in the transcript of this episode. Finally, if you value the insights that you heard today on the ASCO Daily News Podcast, please rate, review, and subscribe wherever you get your podcasts. Thanks a ton. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers:    Dr. Sumanta (Monty) Pal  @montypal  Dr. Matteo Lambertini @matteolambe   Follow ASCO on social media:     @ASCO on Twitter    ASCO on Bluesky   ASCO on Facebook     ASCO on LinkedIn     Disclosures:    Dr. Monty Pal:   Speakers' Bureau: MJH Life Sciences, IntrisiQ, Peerview  Research Funding (Inst.): Exelixis, Merck, Osel, Genentech, Crispr Therapeutics, Adicet Bio, ArsenalBio, Xencor, Miyarsian Pharmaceutical  Travel, Accommodations, Expenses: Crispr Therapeutics, Ipsen, Exelixis  Dr. Matteo Lambertini: Consulting or Advisory Role: Roche, Novartis, Lilly, AstraZeneca, Pfizer, MSD, Exact Sciences, Gilead Sciences, Seagen, Menarini, Nordic Pharma Speakers' Bureau: Takeda, Roche, Lilly, Novartis, Pfizer, Sandoz, Ipsen, Knight Therapeutics, Libbs, Daiichi Sankyo, Gilead Sciences, AstraZeneca, Menarini, AstraZeneca, Menarini Research Funding (Inst.): Gilead Sciences Travel, Accommodations, Expenses: Gilead Sciences, Daiichi Sankyo Europe GmbH, Roche

In this powerful Breast Cancer Awareness Month rerun episode, we're joined once again by renowned breast cancer oncologist Dr. Amy Comander to explore the vital connection between lifestyle medicine and breast cancer prevention, treatment, and survivorship.Dr. Comander shares expert insights on how nutrition, exercise, stress management, and other evidence-based lifestyle changes can significantly reduce your risk of breast cancer, support recovery, and enhance long-term health outcomes.Whether you're a patient, survivor, caregiver, or simply looking to take proactive steps toward better health, this episode offers practical, science-backed strategies for early detection, cancer prevention, and overall wellness. Tune in now to empower yourself with life-changing knowledge and actionable steps from one of the field's leading voices.

Katie Henry has seen some things. From nonprofit bootstraps to Big Pharma boardrooms, she's been inside the machine—and still believes we can fix it. We go deep on her winding road from folding sweaters at J.Crew to launching a vibrator-based advocacy campaign that accidentally changed the sexual health narrative in breast cancer.Katie doesn't pull punches. She's a born problem solver with zero tolerance for pink fluff and performative empathy. We talk survivor semantics, band camp trauma, nonprofit burnout, and why “Didi” is the grandparent alter ego you never saw coming.She's Murphy Brown with a marimba. Veronica Sawyer in pharma. Carla Tortelli with an oncology Rolodex. And she still calls herself a learner.This is one of the most honest, hilarious, and refreshingly real conversations I've had. Period.RELATED LINKS:Katie Henry on LinkedInKatie Henry on ResearchGateLiving Beyond Breast CancerNational Breast Cancer CoalitionFEEDBACK:Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us a textWhat if cancer could be detected years before symptoms ever appear? In this episode of Causes or Cures, Dr. Eeks sits down with Dr. Yuxuan Wang, cancer researcher at Johns Hopkins, to discuss her team's promising work on multicancer early detection (MCED) blood tests.These ultra-sensitive sequencing tests can spot tiny fragments of tumor DNA circulating in the blood. In their recent study, the MCED test flagged early cancer signs in 8 out of 26 participants who were later diagnosed — half of them more than three years before their cancer was picked up clinically. While still experimental and not FDA-approved, this research points to a future where cancer screening might extend well beyond mammograms and colonoscopies.In this episode, we cover:Dr. Wang's journey into cancer research and what inspired her focus.What multicancer early detection (MCED) blood tests are and how they work.How the Johns Hopkins study was designed and what the key results showed.Which cancer types were detected and what limitations still exist.Challenges such as false positives, incidental findings, and overtreatment risks.The ethical and practical questions of telling patients they may have cancer years before symptoms.Cost and accessibility concerns: how to make such tests affordable if approved.Next steps toward larger trials, FDA approval, and clinical use.How MCED could change the landscape of cancer screening and prevention in the future.Balancing public enthusiasm, media attention, and scientific caution.This is a fascinating and nuanced conversation about the possibilities, and challenges, of catching cancer earlier than ever before.You can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Or Facebook here.Or X.On Youtube.Or TikTok.SUBSCRIBE to her monthly newsletter here! (Now featuring interviews with top experts on health you care about!)Support the show

It's no secret that I believe occupation therapy is entering its prevention era. We are starting to leverage our skillset not after a terrible health incident has occurred, but at the first sign of trouble. As I imagine this not-too-distant reality, there is one deeply personal area that I am so eager to see us shift our energy toward: Cancer prevention. Across the healthcare community, we are learning more and more about the specific lifestyle and environmental factors that put people at a higher risk for cancer. Case in point: My own county in rural Nebraska, where above-average pediatric cancer rates have been associated with high levels of nitrates in our water.On today's podcast, we are lucky to be joined by Dr. Jesse E. Bell, one of the world's leading experts on water and human health and the Claire M. Hubbard Professor of Water, Climate, and Health in the University of Nebraska Medical Center's Department of Environmental, Agricultural, and Occupational Health.Dr. Bell—who also is the author of the paper we will discuss during this episode—will help us understand where the science stands on the connection between nitrates and multiple health conditions. We'll talk through ways the medical community can provide education on these risks—as well as the simple solutions OTs could potentially bring to high-risk families to help address this basic ADL safety concern. This episode is meant to highlight the cutting edge of what's becoming possible—where new large datasets on environmental health risks converge with new opportunities in value-based care to create pathways for OTs to intervene earlier than we ever thought possible.Support the show

Cancer prevention isn't just about genetics or luck—it's about understanding the biological environment that either supports or inhibits abnormal cell growth. Research shows up to 70% of cancers are linked to lifestyle and environmental factors, yet many healthcare providers dismiss these prevention strategies as unimportant. In this episode of The Medical Disruptor, Dr. E reveals evidence-based cancer prevention strategies that conventional medicine often overlooks, focusing on four modifiable risk factors you can control today. When you ask about diet, stress management, or environmental toxins in cancer prevention and are told these "don't really matter," you're encountering a limitation of medical training, not scientific evidence. Instead of waiting for a diagnosis or being told there's nothing more you can do, you'll learn how to create a cellular environment that supports health rather than disease. Looking to schedule a consultation with Dr. E? Book here: drefratlamandre.com/consult Check us out on social media: drefratlamandre.com/instagram drefratlamandre.com/facebook drefratlamandre.com/tiktok #functionalmedicine #drefratlamandre #medicaldisruptor #NPwithaPHD #nursepractitioner #medicalgaslighting #CancerPrevention #WomensHealth Learn more about your ad choices. Visit megaphone.fm/adchoices

Modern Life Is Killing Us: Why Your Body Can't Keep Up | Karel Cast 25-118 Human bodies haven't changed in 100,000 years, but our world has. From the rise of agriculture just 10,000 years ago to nonstop modern stress, tech overload, and processed living, we're locked in an evolutionary mismatch—and it's making us sick. Obesity, depression, cancer, and anxiety aren't just random—they're signs our environment is outpacing our biology. Karel breaks down why life today feels like an uphill battle, how modern pressures are breaking us down physically and mentally, and most importantly: what you can do to protect your health and reclaim your time.

Sophie Sargent walked into the studio already owning the mic. A pandemic-era media rebel raised in New Hampshire, trained in Homeland Security (yep), and shaped by rejection, she's built a career out of DM'ing her way into rooms and then owning them. At 25, she's juggling chronic illness, chronic overachievement, and a generation that gets dismissed before it even speaks.We talk Lyme disease, Lyme denial, and the healthcare gaslighting that comes when you “look fine” but your body says otherwise. We dive into rejection as a career accelerant, mental health as content porn, and what it means to chase purpose without sacrificing identity. Sophie's a former morning radio host, country music interviewer, and Boston-based creator with a real voice—and she uses it.No fake podcast voice. No daddy-daughter moment. Just two loudmouths from different planets figuring out what it means to be seen, believed, and taken seriously in a system designed to do the opposite.Spoiler: She's smarter than I was at 25. And she'll probably be your boss someday.RELATED LINKSSophie on InstagramSophie on YouTubeSophie on LinkedInMedium article: “Redefining Rejection”See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What happens when you hand a mic to the most extroverted, uncensored Gen Z career coach in New York? You get Olivia Battinelli—adjunct professor, student advisor, mentor, speaker, and unfiltered truth-teller on everything from invisible illness to resume crimes.We talked about growing up Jewish-Italian in Westchester, surviving the Big Four's corporate Kool-Aid, and quitting a job after 7 months because the shower goals weren't working out. She runs NYU Steinhardt's internship program by day, roasts Takis and “rate my professor” trolls by night, and somehow makes room for maple syrup takes, career coaching, and a boyfriend named Dom who sounds like a supporting character from The Sopranos.She teaches kids how to talk to humans. She's allergic to BS. And she might be the most Alexis Rose-meets-Maeve Wiley-mashup ever dropped into your feed. Welcome to her first podcast interview. It's pure gold.RELATED LINKS:Olivia Battinelli on LinkedInOlivia's Liv It Up Coaching WebsiteOlivia on InstagramNYU Steinhardt Faculty PageFEEDBACK:Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Alliance for Natural Health sues FDA to allow truthful, science-based health claims for 118 vitamins, minerals and nutraceuticals in 1st Amendment test; What to do for H. pylori—or should it even be treated? Whole body MRI for cancer screening—is it worth undertaking? A remarkable new functional food supplement and beverage, harnessing the unique benefits of the muscadine grape. 

Cancer now accounts for nearly two-thirds of firefighter line-of-duty deaths — a risk that extends long after the sirens fade. After 25 years with the Georgetown, Kentucky Fire Department, retired Chief Tim Thompson has made it his mission to change the way fire service approaches cancer prevention.On this episode of The PQI Podcast, Chief Thompson shares how his department integrated advanced cancer screenings into firefighter health programs, gained city support to secure sustainable funding, and launched a nonprofit to cover screenings for retirees. He also reflects on the leadership lessons that shaped his career and why prevention must be built into the culture of service.Now in retirement, he's focused on helping departments nationwide establish lasting cancer screening programs that protect firefighters throughout their careers and beyond.Listen for a conversation on leadership, prevention, and building programs that save lives.

This episode is sponsored by Invivyd, Inc.Marc Elia is a biotech investor, the Chairman of the Board at Invivyd, and a Long COVID patient who decided to challenge the system while still stuck inside it. He's not here for corporate platitudes, regulatory shoulder shrugs, or vaccine-era gaslighting. This is not a conversation about politics, but it's about power and choice and the right to receive care and treatment no matter your condition.In this episode, we cover everything from broken clinical pathways to meme coins and the eternal shame of being old enough to remember Eastern Airlines. Marc talks about what it means to build tools instead of just complaining, what Long COVID has done to his body and his patience, and why the illusion of “choice” in healthcare is a luxury most patients don't have.This conversation doesn't ask for empathy. It demands it.RELATED LINKSMarc Elia on LinkedInInvivyd Company SiteMarc's Bio at InvivydFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

 Hashimoto's, Hormones, Neck Checks & the Future of Thyroid Screening Thyroid cancer is on the rise among midlife women—and most don't even know they're at risk. In this eye-opening episode of Asking for a Friend, Dr. Rashmi Roy, Director of Thyroid Surgical Services at the Clayman Thyroid Center and one of the world's most experienced thyroid surgeons, explains why traditional blood work often misses thyroid cancer completely—and what women can do about it.You'll learn: ✅ Why thyroid cancer rarely shows symptoms and often doesn't appear on routine thyroid labs ✅ The difference between thyroid disease (hypothyroidism, Hashimoto's) and thyroid cancer ✅ The life-saving power of a simple 2-minute self-neck check you can do today ✅ How Dr. Roy's groundbreaking mobile screening program is catching cancers at a higher rate than mammograms and pap smears ✅ Why she's advocating for thyroid ultrasounds to become routine preventive care for women over 30Dr. Roy also shares patient success stories, her journey into thyroid surgery, and practical steps you can take now to protect your thyroid health. Plus, discover her educational YouTube channel, Goiter Guru, where she empowers women with knowledge about thyroid disease and surgery.

If you've ever thought, “I just can't stop eating sugar,” this episode is for you. I'll share what I discovered while reviewing 20 nutrition genomic reports from breast cancer survivors—and the surprising genetic commonalities that explain both difficulties with blood sugar regulation and stronger tendencies toward impulsive cravings. You'll also learn how cancer cells use insulin receptors to fuel their growth, why sugar is about more than just sweets, and how your brain and body work together in the cycle of cravings. Plus, I'll walk you through The 5 S's framework—a simple set of tools to calm cravings and create a terrain that supports healing. Listen now and discover how to nourish yourself with more confidence and trust.   Explore more support: Better Than Before Breast Cancer Life Coaching Membership: https://www.thebreastcancerrecoverycoach.com/lifecoaching   Take the free Sugar Challenge here: https://www.thebreastcancerrecoverycoach.com/sugar   Let's Connect! If this episode helped you breathe a little easier, please share it with a friend or leave a review. Every share helps spread this message of hope, healing, and whole-person wellness.

In this episode I'm really excited to introduce you to Dr. Nasha Winters, who is author of the book "The Metabolic Approach to Cancer." She's a naturopathic doctor and founder of Metabolic Regen University and has created a metabolic approach to helping people prevent and address cancer and metabolic health disorders. I'm so glad she's here with me on How Humans Heal today. Because Dr. Nasha and I are both naturopathic doctors and graduated from naturopathic medical school at a similar time, our paths have crossed many times over the years. We are both passionate about sharing the message that health can be achieved by addressing the root cause of the health issue. We help patients figure out what's going on under the surface and help them understand what that means in terms of what they can implement to make a difference, especially related to cancer. Dr. Nasha's teaches around the world to both lay audiences and professional audiences, and created the Metabolic Regen University as a way to train clinicians in her approach to cancer. In this episode, Dr. Nasha shares her personal experience with ovarian cancer, how she healed herself, and how that inspired her to become a naturopathic doctor. We talk about high risk HPV related cancer, and cancer in general – how to think about it differently, and non-conventional ways to support healing. If you or someone you know is dealing with cancer, or at risk of cancer, this is an essential interview to listen to in your research process to identify alternative and integrative ways to prevent and address cancer, alongside conventional cancer treatment or if/when conventional approaches fail. We're here to help you! LINKS FROM THE EPISODE:   Connect with Dr. Winters: https://metabolicregen.com/    Join Dr. Doni's “Say Goodbye To HPV” Program: https://hpv.doctordoni.com/hpv/checkout-12week-program   Sign up For Dr. Doni's Masterclasses: https://doctordoni.com/masterclasses/    Schedule A Chat With Dr. Doni: https://intakeq.com/new/hhsnib/vuaovx    Read the full episode notes and find more information: https://doctordoni.com/blog/podcasts/ MORE RESOURCES FROM DR. DONI:   Quick links to social media, free guides and programs, and more: https://doctordoni.com/links     Disclosure: Some of the links in this post are product links and affiliate links and if you go through them to make a purchase I will earn a commission at no cost to you. Keep in mind that I link these companies and their products because of their quality and not because of the commission I receive from your purchases. The decision is yours, and whether or not you decide to buy something is completely up to you.

After losing his son to cancer five years ago, Dr. George Beauregard, a twenty-year internal medicine physician and life-long resident of Massachusetts, used his grief to spread an important message. In this episode he joins Dr. Philip Chan to talk about his new book, “Reservations for Nine: A Doctor's Family Confronts Cancer,” as well as important advice on prevention and symptoms that should not be ignored. To learn more about Dr. Beauregard's book, visit www.georgebeauregard.com

Alexion recently launched the second film in its Rare Connections series, Rare Connections in gMG.Managing editor Jack O'Brien talks with Lucid Diagnostics' chief technology and compliance officer Dr. Brian deGuzman about the company's nationwide initiative to provide education and testing for esophageal precancer.He explains how the NFLPA factors into the effort, which launched in Cincinnati, and how it is expanding across the country to address the heightened risk these athletes have for developing esophageal pre-cancer.Check us out at: mmm-online.com  Fast Break theme music: Mark Buergler - On The Run, Triple Scoop Music Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of forward-thinking discussions on AI, streaming, retail media, and more. Explore the latest in omnichannel strategy, personalization, media trust, and data privacy—all under one roof. Don't wait—use promo code PODCAST for $100 off your individual ticket. Click here to register! AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music.

After years of carrying the weight of lead, Shannon and Cooper find a path out from under the darkness and into the sunlight.LEAD: how this story ends is up to us is an audio docudrama series that tells the true story of one child, his mysterious lead poisoning, and his mother's unwavering fight to keep him safe. A true story written by Shannon Burkett. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett.Lead was produced by Shannon Burkett. Co-produced by Jenny Maguire. Featuring Amy Acker, Tom Butler, Dennis T. Carnegie, James Carpinello, Geneva Carr, Dann Fink, Alice Kris, Adriane Lenox, Katie O'Sullivan, Greg Pirenti, Armando Riesco, Shirley Rumierk, Thom Sesma, and Lana Young. Music by Peter Salett. “Joy In Resistance” written by Abena Koomson-Davis and performed by Resistance Revival Chorus. Casting by Alaine Alldaffer and Lisa Donadio. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This episode covers:In this episode, we discuss how to spot the most common (and overlooked) types of skin cancer, the truth about collagen loss and what you can actually do about it, practical tips for daily sun protection, and so much more.Dr. Mary Alice Mina is a Harvard-trained dermatologist, international speaker, author, and host of The Skin Real, a podcast ranked in the top 2.5% globally. As a co-owner of Baucom & Mina Derm Surgery in Atlanta, Georgia, she is a leading expert in procedural dermatology, skin health, and skincare. With nearly two decades of clinical experience, Dr. Mina is celebrated for her artistic eye, surgical precision, and ability to help patients feel radiant at every stage of life.A sought-after speaker, Dr. Mina delivers impactful keynotes and leads workshops and retreats focused on reframing aging, aesthetics, and skin health. Her insights have been featured in major media outlets, including People Magazine, The Wall Street Journal, Glamour, and Huffington Post. Passionate about empowering others, she combines her expertise with practical advice to inspire audiences to embrace their unique beauty and live confidently in their skin.Links mentioned during this episode:Dr. Mina's IG: https://www.instagram.com/drminaskinDr. Mina's Website: https://www.theskinreal.com/Dr. Mina's Podcast: https://podcasts.apple.com/us/podcast/the-skin-real/id1638619358Free Initial Consultation with Dr. Megan: https://p.bttr.to/3a9lfYkLyons' Share Instagram: www.instagram.com/thelyonsshareJoin Megan's Newsletter: www.thelyonsshare.org/newsletter

For weight loss, complete avoidance of ultra-processed foods outperforms mere “healthy diet” comprising minimally-processed items; Research fraud undermines anti-dementia drug pipeline; Comprehensive lifestyle modification program scores against cognitive decline; Women's brains especially vulnerable to Omega-3 deficiencies; Bible says “Lame shall walk again” and 21st century science may soon bring about this miracle; Breakthroughs in rheumatoid arthritis treatment.

The deficits from the lead poisoning continue to intensify, Shannon channels her anger and grief into holding the people who hurt her son responsible.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett.EP4 features Eboni Booth, Sasha Eden, Kevin Kane, April Matthis, Alysia Reiner, and Mandy Siegfried. Casting by Alaine Alldaffer and Lisa Donadio. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Nasha Winters shares her extraordinary journey from being diagnosed with terminal cancer at age 19 to becoming a pioneering force in metabolic oncology. Given just months to live and unable to receive chemotherapy, she embarked on a quest to understand cancer that led to groundbreaking insights about its metabolic and mitochondrial origins.Winters challenges the conventional genetic theory of cancer, explaining how our bodies' "terrain" - influenced by nutrition, stress, toxins, and lifestyle - creates an environment where cancer either thrives or struggles. She details how modern life's rapid changes overwhelm our mitochondria, potentially leading to cancer when these cellular powerhouses can't properly process information.Most provocatively, Dr. Winters reveals how aggressive cancer treatments can sometimes strengthen cancer by killing weaker cells while allowing stronger ones to thrive. She advocates for a balanced approach combining targeted conventional treatments with strategies to strengthen the body's terrain.The conversation explores her innovative projects including a metabolic cancer data platform, specialized supplements, a research laboratory, and plans for an integrative oncology hospital on an organic farm in Arizona - all designed to revolutionize how we understand and treat cancer.BIG IDEACancer isn't simply genetic bad luck but rather a metabolic disease influenced by our environment, nutrition, and lifestyle - and by understanding these factors, we can dramatically improve prevention and treatment outcomes.Narsha Winters contact info•Website:  https://www.drnasha.com/•Instagram:  https://www.instagram.com/drnashawinters/•X:  https://twitter.com/drnashawinters•LinkedIn:  https://www.linkedin.com/in/nasha-winters-796374b6/•Facebook:  https://www.facebook.com/drnashainc•YouTube:  https://www.youtube.com/@DrNashaInc•Tiktok:  https://www.tiktok.com/@drnashawinters•Book: The Metabolic Approach to CancerSend Dr. Ovadia a Text Message. (If you want a response, you must include your contact information.) Dr. Ovadia cannot respond here. To contact his team, please send an email to team@ifixhearts.com Like what you hear? Head over to IFixHearts.com/book to grab a copy of my book, Stay Off My Operating Table. Ready to go deeper? Talk to someone from my team at IFixHearts.com/talk.Stay Off My Operating Table on X: Dr. Ovadia: @iFixHearts Jack Heald: @JackHeald5 Learn more: Stay Off My Operating Table on Amazon Take Dr. Ovadia's metabolic health quiz: iFixHearts Dr. Ovadia's website: Ovadia Heart Health Jack Heald's website: CultYourBrand.com Theme Song : Rage AgainstWritten & Performed by Logan Gritton & Colin Gailey(c) 2016 Mercury Retro RecordingsAny use of this intellectual property for text and data mining or computational analysis including as training material for artificial intelligence systems is strictly prohibited without express written consent from Dr. Philip Ovadia.

Send us a textOur guest is Dr. Mina a board certified Dermatologist who is sharing so much great information with us. I love her take with internal wellness and our skin, her take on skin minimalism, and what skin treatments are just a bunch of hype. We talk about how to prevent skin cancer and about sun protection. She is a wealth of knowledge and she has her own podcast called the Skin Real.Find Dr. Mina Below!Dr. Mary Alice Mina is a Harvard-trained dermatologist, international speaker, author, and host of The Skin Real, a podcast ranked in the top 2.5% globally. As a co-owner of Baucom & Mina Derm Surgery in Atlanta, Georgia, she is a leading expert in procedural dermatology, skin health, and skincare. With nearly two decades of clinical experience, Dr. Mina is celebrated for her artistic eye, surgical precision, and ability to help patients feel radiant at every stage of life.Click here: www.theskinreal.comCheck out the new app:Apple StoreGoogle Play StoreFind Jess below!Website: Simply Jess Skincare SIMPLY JESS SKINCARE:Each and every product is naturally derived, highly concentrated and most importantly, super performing! Every product was born out of a need to have a truly pure product that met my high standards for efficacy. Subscribe to Our Newsletter! You can take 20% off Your Order of our all natural skincare line with code: PODCAST Shop Now! Favorite Supplements for Health and Fat loss: Click HERE My favorites are the Power Greens, Digestive Enzymes and Brain Power Mushroom Coffee-15% off with Code: SIMPLYJESSSKINCARE15 Click HereEmail Us! jess@learningtoglow.comFollow us! Instagram Tik Tok

The effects of the neurotoxin are taking their toll on Cooper as Shannon desperately tries to navigate the severity of their new reality.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett.E43 features Jenny Maguire, JD Mollison, Laith Nakli, Deirdre O'Connell, Carolyn Baeumler, Zach Shaffer, and Monique Woodley. Casting by Alaine Alldaffer and Lisa Donadio. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Broadcast from KSQD, Santa Cruz on 8-14-2025: Dr. Dawn shares the story of Tim Fried, a construction worker who deliberately exposed himself to 850 snake venom doses over 18 years to build immunity. An immunologist developed antivenom from Fried's antibodies that neutralizes venom from 19 deadly snake species, potentially saving thousands of lives annually from snakebite deaths. She describes cuttlefish sign language research revealing four specific arm movements. The cuttlefish respond to videos and water vibrations from these signs, suggesting complex communication abilities rather than simple mimicry, potentially comparable to octopus intelligence. New research challenges the assumption that Neanderthals were hyper-carnivores. While bone nitrogen levels suggested a meat-only diet, dental evidence showed plant consumption. Researchers now theorize Neanderthals ate maggots from rotting meat, which contain 43% more nitrogen than flesh and would explain the contradictory evidence between bone chemistry and tooth wear patterns. CPR guidelines may soon from the traditional ABC approach (airway, breathing, circulation) to focusing immediately on chest compressions. Research on 45 collapsed athletes showed that 27 who received inappropriate airway clearing died or remained comatose, while three who received immediate rapid chest compressions survived with potential for rehabilitation. The recommendationcould become 100-120 compressions per minute without preliminary airway management. Dr. Dawn presents reassuring statistics about spinal abnormalities in pain-free adults over 60. MRI studies show 90% have disc degeneration, 80% have disc bulges, and 40% have protrusions - yet these individuals have no back pain. This raises questions about attributing back pain to imaging findings when so many similar abnormalities exist in asymptomatic people. Australian cockatoos have learned to operate drinking fountains for entertainment rather than necessity. Researchers observed 70 birds attempting and 40 successfully using fountains, waiting in organized lines and taking turns, despite easier water sources being available nearby. An emailer asks about Essiac tea for cancer prevention. Dr. Dawn explains this herbal blend of burdock root, Indian rhubarb, sheep sorrel, and slippery elm shows promise in laboratory studies but lacks quality human research. While not harmful, no studies demonstrate reduced cancer recurrence rates, though the antioxidant properties may provide general health benefits. Another emailer inquires about lithium supplements for Alzheimer's prevention. Dr. Dawn discusses research showing lower brain lithium levels in Alzheimer's patients and how amyloid plaques trap lithium. Studies suggest lithium orotate (unlike lithium carbonate) isn't absorbed by plaques and may help memory in mice. Low-dose lithium orotate appears safe and mildly calming for humans. Groundbreaking research shows exercise dramatically improves colon cancer survival. A study of 900 patients found the exercise group had 80% five-year disease-free survival versus 74% in controls, with 40% reduced death risk. The intensive program required 10 METs weekly exercise with behavioral support sessions over three years. Dr. Dawn explores coffee's health benefits, noting humanity consumes 2 billion cups daily. Multiple studies show moderate consumption (3-4 cups) reduces breast cancer risk in postmenopausal women and slows Parkinson's progression. Compounds like cafestol and chlorogenic acids provide anti-inflammatory and antioxidant effects, though benefits disappear when adding significant cream or sugar. She warns about Chikungunya outbreaks in China affecting over 8,000 people. This mosquito-borne illness causes severe bone pain and can spread through blood transfusion. With increased global travel and climate change expanding mosquito ranges, Dr. Dawn emphasizes the importance of volunteering travel history to healthcare providers when presenting with fever and body aches.

As the lead wreaks havoc on Cooper's development, Shannon searches for answers. Desperate to get a handle on what was happening to her son, she grabs onto a lifeboat - nursing school. Andy tries to piece together the past to make sense of the present.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper BurkettEP2 features Keith Nobbs and Frank Wood. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes. Casting by Alaine Alldaffer and Lisa Donadio.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.